Bright.md, the provider of a virtual healthcare service backed by StartX, has raised $8m in its latest funding round.

Lightox, Horizon: Therapeutic Microbubbles and StrataStem are among the companies that will receive support from the North of England Life Sciences Accelerator.

Lundbeck's corporate venturing unit contributed to a series C round led by New Enterprise Associates which will advance Trevi Therapeutics' lead pruritus treatment.

GE Ventures has led a $14.1m series C round for online health insurance marketplace Gravie, a year after the company received $1m from insurer Securian.

Shandong Buchang Pharmaceuticals has taken part in a $17.7m round for Symbow Medical, which is working on a surgical navigation device.

Mayo Clinic, which co-launched artificial intelligence-equipped drug developer Qrative with AI software provider Nference, has also contributed to its $8.3m series A round.

Novo participated in Menlo's series C round, which follows the completion of two clinical trials for the skin condition drug developer's lead product candidate.

Tasly Pharma has led a series E round for PegBio, which is working on drugs to treat diabetes and obesity, and which is also backed by Legend Holdings.

Medication Management Systems, a University of Minnesota spinout, has been acquired for an undisclosed sum.